J Bone Metab.  2017 May;24(2):83-89. 10.11005/jbm.2017.24.2.83.

Sarcopenia: Neurological Point of View

• Kwon YN
• Yoon SS

• KMID: 2379989
• DOI: http://doi.org/10.11005/jbm.2017.24.2.83

Abstract

Sarcopenia is an age-related geriatric syndrome which is characterized by the gradual loss of muscle mass, muscle strength, and muscle quality. There are a lot of neurologic insults on sarcopenia at various levels from the brain to the neuromuscular junctions (NMJs) to generate a volitional task. Dopaminergic downregulation, inadequate motor programming and motor coordination impairment lead to decline of supraspinal drive. Motor unit reorganization and inflammatory changes in motor neuron decrease conduction velocity and amplitude of compound muscle action potential. Furthermore, NMJ remodeling and age related neurophysiological alterations may contribute to neuromuscular impairment. Sarcopenia is an age-associated, lifelong process which links to multiple etiological factors. Although not all the causes are completely understood, we suggest that compromised nervous system function may be one of the important contributors to the sarcopenia.

Keyword

Aging; Motor neurons; Nervous system; Neuromuscular junction; Sarcopenia

MeSH Terms

Action Potentials
Aging
Ataxia
Brain
Down-Regulation
Motor Neurons
Muscle Strength
Nervous System
Neuromuscular Junction
Sarcopenia*

Figure

• 

  Fig. 1 Potential sites and physiological mechanisms that regulate strength. The neuromuscular system contains several potential sites that can affect voluntary force or power production, such as 1) excitatory drive from supraspinal centers, 2) α-motoneuron excitability, 3) antagonistic muscle activity, 4) motor unit recruitment and rate coding, 5) neuromuscular transmission, 6) muscle mass, 7) excitation-contraction coupling processes, and 8) muscle morphology and architecture. [Reprinted from “Sarcopenia =/= dynapenia”, by Clark BC and Manini TM, 2008, J Gerontol A Biol Sci Med Sci, 63, pp.829-34.

• 

  Fig. 2 Summary of neurological mechanisms of sarcopenia. EPSP, excitatory postsynaptic potentials; NCV, nerve conduction velocity; CMAP, compound muscle action potentials; NMJ, neuromuscular junction.

• 

  Fig. 3 Effect of age on the motor unit, depicting, young and aged motor units. This drawing depicts the pronounced denervation of type II fibers and the recruitment of type I fibers into surviving motor units in older subjects.

• 

  Fig. 4 Anatomical remodeling at neuromuscular junction; 1) Widening of synaptic clefts, 2) degeneration of junctional folds at the post synaptic region, and 3) the number of perijunctional acetylcholine receptors is increased.

Reference

1. Kwan P. Sarcopenia, a neurogenic syndrome? J Aging Res. 2013; 2013:791679.

2. Clark BC, Manini TM. Sarcopenia =/= dynapenia. J Gerontol A Biol Sci Med Sci. 2008; 63:829–834.

3. Janssen I. Evolution of sarcopenia research. Appl Physiol Nutr Metab. 2010; 35:707–712.

4. Visser M, Schaap LA. Consequences of sarcopenia. Clin Geriatr Med. 2011; 27:387–399.

5. Reid KF, Naumova EN, Carabello RJ, et al. Lower extremity muscle mass predicts functional performance in mobility-limited elders. J Nutr Health Aging. 2008; 12:493–498.

6. Goodpaster BH, Carlson CL, Visser M, et al. Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study. J Appl Physiol (1985). 2001; 90:2157–2165.

7. Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci. 2002; 57:M772–M777.

8. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002; 50:889–896.

9. Sanchis-Gomar F, Gómez-Cabrera MC, Viña J. The loss of muscle mass and sarcopenia: non hormonal intervention. Exp Gerontol. 2011; 46:967–969.

10. Bhasin S. Testosterone supplementation for aging-associated sarcopenia. J Gerontol A Biol Sci Med Sci. 2003; 58:1002–1008.

11. Giovannini S, Marzetti E, Borst SE, et al. Modulation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults. Mech Ageing Dev. 2008; 129:593–601.

12. Bhanushali M, Conwit R, Metter J, et al. The role of the nervous system in muscle atrophy. In : Cruz-Jentoft AJ, Morley JE, editors. Sarcopenia. Chichester, UK: John Wiley and Sons;2012. p. 41–58.

13. Kaasinen V, Vilkman H, Hietala J, et al. Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain. Neurobiol Aging. 2000; 21:683–688.

14. Dreher JC, Kohn P, Kolachana B, et al. Variation in dopamine genes influences responsivity of the human reward system. Proc Natl Acad Sci U S A. 2009; 106:617–622.

15. Volkow ND, Fowler JS, Wang GJ, et al. Decreased dopamine transporters with age in health human subjects. Ann Neurol. 1994; 36:237–239.

16. Seidler RD, Bernard JA, Burutolu TB, et al. Motor control and aging: links to age-related brain structural, functional, and biochemical effects. Neurosci Biobehav Rev. 2010; 34:721–733.

17. Marchand WR, Lee JN, Suchy Y, et al. Age-related changes of the functional architecture of the cortico-basal ganglia circuitry during motor task execution. Neuroimage. 2011; 55:194–203.

18. Sterr A, Dean P. Neural correlates of movement preparation in healthy ageing. Eur J Neurosci. 2008; 27:254–260.

19. Coxon JP, Goble DJ, Van Impe A, et al. Reduced basal ganglia function when elderly switch between coordinated movement patterns. Cereb Cortex. 2010; 20:2368–2379.

20. Matsuda H. Voxel-based morphometry of brain MRI in normal aging and Alzheimer's disease. Aging Dis. 2013; 4:29–37.

21. Romero DH, Stelmach GE. Motor function in neurodegenerative disease and aging. In : Boller F, Cappa SF, editors. Handbook of neuropsychology. New York, NY: Elsevier;2001. p. 163–191.

22. Cham R, Studenski SA, Perera S, et al. Striatal dopaminergic denervation and gait in healthy adults. Exp Brain Res. 2008; 185:391–398.

23. van Dyck CH, Avery RA, MacAvoy MG, et al. Striatal dopamine transporters correlate with simple reaction time in elderly subjects. Neurobiol Aging. 2008; 29:1237–1246.

24. Raz N, Lindenberger U, Rodrigue KM, et al. Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. Cereb Cortex. 2005; 15:1676–1689.

25. Eisen A, Entezari-Taher M, Stewart H. Cortical projections to spinal motoneurons: changes with aging and amyotrophic lateral sclerosis. Neurology. 1996; 46:1396–1404.

26. Smith AE, Sale MV, Higgins RD, et al. Male human motor cortex stimulus-response characteristics are not altered by aging. J Appl Physiol (1985). 2011; 110:206–212.

27. Zhang C, Goto N, Suzuki M, et al. Age-related reductions in number and size of anterior horn cells at C6 level of the human spinal cord. Okajimas Folia Anat Jpn. 1996; 73:171–177.

28. Cruz-Sánchez FF, Moral A, Tolosa E, et al. Evaluation of neuronal loss, astrocytosis and abnormalities of cytoskeletal components of large motor neurons in the human anterior horn in agingx. J Appl Physiol (1985). 1998; 105:689–701.

29. Tomlinson BE, Irving D. The numbers of limb motor neurons in the human lumbosacral cord throughout life. J Neurol Sci. 1977; 34:213–219.

30. Cruz-Sánchez FF, Moral A, Rossi ML, et al. Synaptophysin in spinal anterior horn in aging and ALS: an immunohistological study. J Neural Transm (Vienna). 1996; 103:1317–1329.

31. Sale MV, Semmler JG. Age-related differences in corticospinal control during functional isometric contractions in left and right hands. J Appl Physiol (1985). 2005; 99:1483–1493.

32. Doherty TJ, Brown WF. The estimated numbers and relative sizes of thenar motor units as selected by multiple point stimulation in young and older adults. Muscle Nerve. 1993; 16:355–366.

33. Ling SM, Conwit RA, Ferrucci L, et al. Age-associated changes in motor unit physiology: observations from the Baltimore Longitudinal Study of Aging. Arch Phys Med Rehabil. 2009; 90:1237–1240.

34. Christie A, Kamen G. Doublet discharges in motoneurons of young and older adults. J Neurophysiol. 2006; 95:2787–2795.

35. Kamen G. Aging, resistance training, and motor unit discharge behavior. Can J Appl Physiol. 2005; 30:341–351.

36. Jesunathadas M, Marmon AR, Gibb JM, et al. Recruitment and derecruitment characteristics of motor units in a hand muscle of young and old adults. J Appl Physiol (1985). 2010; 108:1659–1667.

37. Dorfman LJ, Bosley TM. Age-related changes in peripheral and central nerve conduction in man. Neurology. 1979; 29:38–44.

38. Metter EJ, Conwit R, Metter B, et al. The relationship of peripheral motor nerve conduction velocity to age-associated loss of grip strength. Aging (Milano). 1998; 10:471–478.

39. Lauretani F, Bandinelli S, Bartali B, et al. Axonal degeneration affects muscle density in older men and women. Neurobiol Aging. 2006; 27:1145–1154.

40. Grounds MD. Reasons for the degeneration of ageing skeletal muscle: a central role for IGF-1 signalling. Biogerontology. 2002; 3:19–24.

41. Grounds MD, Radley HG, Gebski BL, et al. Implications of cross-talk between tumour necrosis factor and insulin-like growth factor-1 signalling in skeletal muscle. Clin Exp Pharmacol Physiol. 2008; 35:846–851.

42. Aagaard P, Suetta C, Caserotti P, et al. Role of the nervous system in sarcopenia and muscle atrophy with aging: strength training as a countermeasure. Scand J Med Sci Sports. 2010; 20:49–64.

43. Tam SL, Gordon T. Mechanisms controlling axonal sprouting at the neuromuscular junction. J Neurocytol. 2003; 32:961–974.

44. Hantaï D, Akaaboune M, Lagord C, et al. Beneficial effects of insulin-like growth factor-I on wobbler mouse motoneuron disease. J Neurol Sci. 1995; 129:Suppl. 122–126.

45. Luff AR. Age-associated changes in the innervation of muscle fibers and changes in the mechanical properties of motor units. Ann N Y Acad Sci. 1998; 854:92–101.

46. Tam SL, Gordon T. Neuromuscular activity impairs axonal sprouting in partially denervated muscles by inhibiting bridge formation of perisynaptic Schwann cells. J Neurobiol. 2003; 57:221–234.

47. Deschenes MR. Effects of aging on muscle fibre type and size. Sports Med. 2004; 34:809–824.

48. Jang YC, Van Remmen H. Age-associated alterations of the neuromuscular junction. Exp Gerontol. 2011; 46:193–198.

49. Schiaffino S, Murgia M, Serrano AL, et al. How is muscle phenotype controlled by nerve activity? Ital J Neurol Sci. 1999; 20:409–412.

50. Alway SE, Degens H, Krishnamurthy G, et al. Denervation stimulates apoptosis but not Id2 expression in hindlimb muscles of aged rats. J Gerontol A Biol Sci Med Sci. 2003; 58:687–697.

51. Wokke JH, Jennekens FG, van den Oord CJ, et al. Morphological changes in the human end plate with age. J Neurol Sci. 1990; 95:291–310.

52. Oda K. Age changes of motor innervation and acetylcholine receptor distribution on human skeletal muscle fibres. J Neurol Sci. 1984; 66:327–338.